文献速递瓣膜外科

二尖瓣疾病病因对二尖瓣手术围术期死亡率的影响

The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations.
PubMed 文献 · Ann Thorac Surg · 2018-05-16

基于美国胸外科医师学会数据库2011至2014年89,085例二尖瓣修复或置换患者,按病因决策树分为八组。未校正死亡率从退行性二尖瓣修复的1.2%到急性缺血性功能性二尖瓣反流置换的15.1%不等,但风险校正后二尖瓣病因本身与围术期死亡率无显著独立关联,死亡率主要由标准临床危险因素决定。

要点

  • 未校正围术期死亡率最低为退行性二尖瓣修复1.2%,最高为急性缺血性功能性二尖瓣反流置换15.1%。
  • 风险校正后,二尖瓣病因本身与围术期死亡率无显著独立关联。
  • 二尖瓣术后死亡率主要由标准临床危险因素决定,病因不增加独立预测价值。

核心结论

  • 二尖瓣术后死亡率主要由标准临床危险因素决定,二尖瓣病因本身似乎不增加独立预测价值。

研究设计与样本

  • 利用美国胸外科医师学会数据库评估2011至2014年所有接受二尖瓣置换或修复的患者。
  • 纳入同期行外科消融、室间隔缺损修补、三尖瓣修复或冠状动脉旁路移植术的患者,排除其他所有同期手术,最终队列89,085例。
  • 采用分层病因决策树将人群分为八组:心内膜炎、再次手术、急性缺血性功能性二尖瓣反流、风湿性、不常见病因(肥厚型梗阻性心肌病、创伤、肿瘤或先天性)、退行性原发性二尖瓣反流、慢性缺血性功能性二尖瓣反流和单纯瓣环扩张。
  • 通过逻辑回归评估病因与未校正及风险校正围术期死亡率的统计学关联,并使用已建立的风险模型进行敏感性分析作为补充。

主要发现

  • 决策树显示病因分类在临床上与已发表的人群分布、基线特征和未校正结局相符。
  • 未校正围术期死亡率范围为退行性二尖瓣修复的1.2%至急性缺血性功能性二尖瓣反流二尖瓣置换的15.1%。
  • 风险校正后,各二尖瓣病因本身与风险校正围术期死亡率无显著独立关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The pathoetiology of mitral regurgitation (MR) has been suggested as a mediator of outcomes after mitral valve (MV) operations, particularly in ischemic functional mitral regurgitation (IMR). This study examined the independent association of MV etiology with mortality. METHODS: The Society of Thoracic Surgeons Database was utilized to assess all patients undergoing MV replacement or repair from 2011 to 2014. Patients who underwent concomitant surgical ablation, septal defect closure, tricuspid valve repair, or coronary artery bypass grafting were included. All other concomitant operations were excluded, producing a final cohort of 89,085 patients. A hierarchical etiology decision tree was developed to categorize the population into eight etiology groups: endocarditis, reoperation, acute IMR, rheumatic, uncommon etiologies (hypertrophic obstructive cardiomyopathy, trauma, tumor, or congenital), degenerative primary MR, chronic IMR, and pure annular dilatation. The statistical association of etiology with unadjusted and risk-adjusted operative mortality was evaluated by logistic regression and supplemented by sensitivity analyses using established risk models. RESULTS: The decision tree showed that etiology categories appeared clinically aligned with published population distributions, baseline characteristics, and unadjusted outcomes. Unadjusted operative mortality ranged from 1.2% for degenerative MV repair to 15.1% for MV replacement in acute IMR. After risk adjustment, MV etiologies per se exhibited insignificant independent associations with risk-adjusted operative mortality. CONCLUSIONS: Mortality after mitral operations is determined primarily by standard clinical risk factors. Mitral etiology does not appear to add independent predictive value.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Rankin JS, Grau-Sepulveda M, Shahian DM, et al. The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations. Ann Thorac Surg. 2018. PMID: 29777670. doi:10.1016/j.athoracsur.2018.04.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。